A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis

2017 ◽  
Vol 293 ◽  
pp. 43-52 ◽  
Author(s):  
Stefania Marcuzzo ◽  
Silvia Bonanno ◽  
Matteo Figini ◽  
Alessandro Scotti ◽  
Ileana Zucca ◽  
...  
2020 ◽  
Vol 598 (19) ◽  
pp. 4385-4403
Author(s):  
Dennis B. Jensen ◽  
Marion Kadlecova ◽  
Ilary Allodi ◽  
Claire F. Meehan

2006 ◽  
Vol 8 (11-12) ◽  
pp. 2075-2087 ◽  
Author(s):  
Kenneth Hensley ◽  
Molina Mhatre ◽  
Shenyun Mou ◽  
Quentin N. Pye ◽  
Charles Stewart ◽  
...  

2007 ◽  
Vol 25 (6) ◽  
pp. 1669-1677 ◽  
Author(s):  
Heiko G. Niessen ◽  
Grazyna Debska-Vielhaber ◽  
Kerstin Sander ◽  
Frank Angenstein ◽  
Albert C. Ludolph ◽  
...  

2018 ◽  
Vol 39 (7) ◽  
pp. 1283-1298 ◽  
Author(s):  
Hongxia Lei ◽  
Elisabeth Dirren ◽  
Carole Poitry-Yamate ◽  
Bernard L Schneider ◽  
Rolf Gruetter ◽  
...  

In vivo 1H magnetic resonance spectroscopy (1H-MRS) investigations of amyotrophic lateral sclerosis (ALS) mouse brain may provide neurochemical profiles and alterations in association with ALS disease progression. We aimed to longitudinally follow neurochemical evolutions of striatum, brainstem and motor cortex of mice transgenic for G93A mutant human superoxide dismutase type-1 (G93A-SOD1), an ALS model. Region-specific neurochemical alterations were detected in asymptomatic G93A-SOD1 mice, particularly in lactate (−19%) and glutamate (+8%) of brainstem, along with γ-amino-butyric acid (−30%), N-acetyl-aspartate (−5%) and ascorbate (+51%) of motor cortex. With disease progression towards the end-stage, increased numbers of metabolic changes of G93A-SOD1 mice were observed (e.g. glutamine levels increased in the brainstem (>+66%) and motor cortex (>+54%)). Through ALS disease progression, an overall increase of glutamine/glutamate in G93A-SOD1 mice was observed in the striatum ( p < 0.01) and even more so in two motor neuron enriched regions, the brainstem and motor cortex ( p < 0.0001). These 1H-MRS data underscore a pattern of neurochemical alterations that are specific to brain regions and to disease stages of the G93A-SOD1 mouse model. These neurochemical changes may contribute to early diagnosis and disease monitoring in ALS patients.


2007 ◽  
Vol 353 (3) ◽  
pp. 719-725 ◽  
Author(s):  
Tania Massignan ◽  
Filippo Casoni ◽  
Manuela Basso ◽  
Paola Stefanazzi ◽  
Emiliano Biasini ◽  
...  

2006 ◽  
Vol 7 (4) ◽  
pp. 227-232 ◽  
Author(s):  
Svitlana Garbuzova‐Davis ◽  
Alison E. Willing ◽  
Samuel Saporta ◽  
Eleanor B. Justen ◽  
Iwona E. Misiuta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document